Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 2
Safety and efficacy of doxycycline in the treatment of rosacea
Authors Valentin S, Morales A, Sanchez J, Abimael R
Published 12 August 2009 Volume 2009:2 Pages 129—140
DOI https://doi.org/10.2147/CCID.S4296
Review by Single anonymous peer review
Peer reviewer comments 2
Sheila Valentín, Adisbeth Morales, Jorge L Sánchez, Abimael Rivera
Department of Dermatology, University of Puerto Rico, School of Medicine, San Juan, Puerto Rico
Abstract: Rosacea is a common, chronic, skin condition characterized by recurrent episodes of facial flushing, transient or persistent erythema, papules, pustules, and telangiectasias, in a symmetrical facial distribution. The etiology of rosacea remains unknown and this condition represents a therapeutic challenge because of its chronic nature, progression, potential for disfigurement and psychological impact. Although there is no curative therapy for rosacea, the most widely used systemic agents are oral tetracycline derivatives, including tetracycline, doxycycline, and minocycline. This article reviews the available evidence for the use of doxycycline, a second-generation tetracycline, in the treatment or rosacea.
Keywords: rosacea, doxycyline, tetracyclines
© 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.